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Background:  Perioperative opioid administration results in postoperative nausea and vomiting (PONV) and acute 
opioid tolerance that manifests in increased postoperative pain.  Esmolol is an ultra short acting cardioselective β1- 
adrenergic receptor antagonist, and it has been successfully used for perioperative sympatholysis and it reduces 
the opioid requirement during total intravenous anesthesia.  We tested the hypothesis that perioperative esmolol 
administration results in decreased PONV and postoperative pain.
Methods:  Sixty patients undergoing laparoscopic appendectomy were randomly assigned to two groups (Group E 
and Group C).  The Group E patients were administered 5-10 μg/kg/min esmolol with remifentanil that was titrated 
to the autonomic response.  The Group C patients received normal saline that was of the same volume as the esmolol 
in Group E, and the remifentanil was also titrated to the vital sign.  Before intubation and extubation, the Group E 
patients were administered 1.0 mg/kg esmolol, and the Group C patients were administered normal saline of the 
same volume.  The incidence and severity of PONV, the pain score, the rescue antiemetics and the rescue analgesics 
were assessed 30 min, 6 h and 24 h after surgery.  The mean arterial pressure and heart rate under anesthesia were 
also recorded.
Results:  PONV and postoperative pain were significantly increased in Group C.  These patients needed more 
antiemetics and analgesics in the first 24 postoperative hours.  The mean arterial pressure and heart rate were 
significantly higher in Group C at the time of intubation and extubation.
Conclusions:  Perioperative esmolol administration contributes to the significant decrease in PONV and 
postoperative pain, and so this facilitates earlier discharge.  (Korean J Anesthesiol 2010; 59: 179-184)
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Introduction
    The development of anesthetics has facilitated quick 
anesthetic induction, the use of awake anesthesia and safe 
recovery. The advancement of tools and skills has allowed 
laparoscopic appendectomies to be performed in a short 
time and usually within 30 minutes. Because laparoscopic 
appendectomies require only a small incision and a low level 
of organ manipulation, they cause less pain and enteroplegia 
compared to laparatomies, and they allow for earlier discharge 
from the hospital [1]. Therefore, with the patient under general 
anesthesia, laparoscopic appendectomy allows faster and safer 
recovery. 
    Total intravenous anesthesia using propofol and remifentanil 
is commonly preferred because of its better rates of recovery 
of consciousness and the lower rate of PONV and pain after 
ceasing the administration of anesthetics [2]. PONV and pain 
following laparoscopy are the main causes for lengthening the 
period of hospitalization [3,4]. 
    Esmolol is a β-adrenergic receptor antagonist that selectively 
affects the cardiovascular system. Its effect is rapid and it has a 
short half life. It is used as an anesthetic supplement to reduce 
the hemodynamic responses to surgical stimulation. This 
β-adrenergic receptor antagonist has a sympathetic nerve 
blocking effect on PONV and pain [5]. 
    This study attempted to see the effects of a perioperative 
continuous infusion of esmolol on the PONV and pain in 
laparoscopic appendectomies with the patient under total 
intravenous anesthesia using propofol and remifentanil. 
Materials and Methods
    The study was performed on 60 patients between the ages 
18-45, their ASA class was I or II and they were undergoing 
laparoscopic appendectomy. They were randomly placed 
into 2 groups: Group E (esmolol group, n = 30) and Group C 
(Group C, n = 30). The following patients were excluded from 
the study: the patients with side-effects or hypersensitivity 
towards the tested drugs, those with cardiovascular diseases, 
metabolic diseases, renal diseases, liver diseases, neurological 
disorders or pregnancy, those women who were breast-feeding 
and those who had taken antiemetics within the last 48 
hours before the surgery. With the approval of the hospital’s 
ethics committee, we visited patients before the surgery 
and explained the purpose of this research and we obtained 
their written consent. Thirty minutes before the surgery, 
glycopyrrolate 0.2 mg was intramuscularly administered to all 
the patients as premedication. Before anesthetic induction, 
the ECG, the automated noninvasive blood pressure device, 
the pulse-oximeter, the bispectral index (BIS) sensor and a 
thermometer were attached to the patients for monitoring. 
Before endotracheal intubation, Group E was intravenously 
administered with esmolol 1.0 mg/kg, and Group C was 
intravenously administered the same amount of normal saline. 
For anesthetic induction, propofol 2 mg/kg and rocuronium 
0.8 mg/kg were intravenously administered before tracheal 
intubation. With a perioperative continuous infusion of 
remifentanil 0.2-0.5 μg/kg/min and propofol 75-85 μg/kg/
min, the mean arterial blood pressure and heart rate were 
maintained within the preoperative levels. After anesthetic 
induction, Group E was continuously infused with esmolol 
10 μg/kg/min and Group C was continuously infused with 
the same amount of normal saline. When perioperative 
hypotension (the mean arterial pressure below 60 mmHg) 
or bradycardia (the heartbeat rate below 40 bpm) occurred, 
ephedrine 10 mg or atropine 0.5 mg was intermittently 
administered in both groups.
    Two surgeons who were experienced with laparoscopic 
appendectomy performed all the surgeries. Intraperitoneal 
CO2 insufflation was formed, and the peritoneal pressure 
was maintained at 12 mmHg during the surgery. After the 
intraperitoneal CO2 insufflation, the patients were placed in the 
Trendelenburg position and their left sides were turned down 
so that there was better access to the appendix. 
    To prevent surgical awareness and maintain an appropriate 
anesthetic depth during anesthesia in both groups, the 
remifentanil concentration was adjusted so that the BIS index 
reached 40-60. Mechanical ventilation was set so that the 
inhaled oxygen concentration reached 50% mixed with air. 
The end tidal CO2 was maintained at the normal level. For 
additional nerve muscle relaxation, rocuronium 0.1 mg/kg was 
intravenously administered, and warming blankets were used 
perioperatively to maintain the normal body temperature.
    After skin-suturing, the intravenous infusion of propofol and 
remifentanil was stopped. For post-operative reversal of muscle 
relaxation, glycopyrrolate 0.008 mg/kg and pyridostigmine 
0.03 mg/kg were mixed and intravenously infused. Right 
before extubation, Group E was infused with esmolol 1.0 mg/
kg, and Group C was infused with natural saline of the same 
amount. After extubation, the continuous infusions of esmolol 
and natural saline were stopped. Drugs that could affect post-
operative nausea and vomiting were not administered, and the 
amounts of remifentanil and esmolol administered up to that 
point were recorded. 
    For both groups, the patients’ age, gender, weight, height, 
the length of operation, the length of time under anesthesia, 
the amount of perioperative fluid administration, smoker or 
nonsmoker, the presence of PONV and nausea, the amounts 
of perioperative infusion of esmolol, remifentanil and propofol 
and the time from the arrival into the recovery room to the time 181 www.ekja.org
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of discharge were all recorded.
    In both groups, the presence and levels of pain, nausea and 
vomiting were recorded 30 minutes, 6 hours and 24 hours after 
the surgery. The recording was done by a person not involved 
with the anesthesia. There were 4 levels of nausea and vomiting 
(free, mild, moderate, severe) [6]. Free was defined as the 
absence of nausea and vomiting. Mild was when there was light 
nausea. Moderate was with 1-2 gag reflexes without actual 
vomiting and antiemetics were required. Severe was vomiting at 
least once or experiencing nausea at least twice and antiemetics 
were required at least once. 
    Metoclopramide 10 mg was administered by IV when the 
patient required antiemetics due to severe post-operative 
vomiting or continuous nausea. The level of pain was measured 
on a visual analogue scale (VAS) with grid points where 100 was 
the maximum and O indicated no pain. If the VAS score was 
30+ or if the patient required analgesics, then diclofenac 90 mg 
was intramuscularly infused. The patients were discharged if 
they had no fever, bowel sounds could be heard and they could 
normally digest food. 
    In both groups, the mean arterial pressure (MAP) and heart 
rate (HR) were measured right before anesthetic induction, at 
the point of endotracheal intubation, 5 minutes after intubation, 
at the point of incision, 10 minutes after incision, at the point of 
extubation, 5 minutes after extubation and at the arrival point 
into the recovery room. 
    The recorded scores are shown as the mean ± standard 
deviation (SD) based on the percent of the number of patients 
(%). The patients’ characteristics were compared with the 
VAS scores, and the MAP was compared with the HR using 
independent t-tests. PONV comparisons were done using 
the chi-square test. A P value of 0.05 or less was considered 
significant. 
Results
    There were no significant differences found in the age, weight, 
height, the length of surgery, the length of anesthesia, the 
administered amount of fluid or the perioperatively amount 
of administered propofol. There were also no significant diffe-
rences in the number of women who were more vulnerable to 
PONV, the patients with the history of PONV, the patients with 
the history of motion sickness and the nonsmokers (Table 1). 
    The amount of remifentanil perioperatively used in Group E 
was 191.2 ± 58.8 mg and it was 285.4 ± 68.2 mg in Group C. So 
Group E used a smaller amount of remifentanil (P = 0.035). The 
length of hospitalization from the point of post-surgery to the 
point of discharge was shorter in Group E (31.7 ± 8.1 h) than 
that in Group C (40.6 ± 9.5 h) (P = 0.027), (Table 1).
    The rate of not experiencing PONV 30 minutes after the 
surgery was 77% in Group E (N = 23) and 43% in Group C (N 
= 13) (P = 0.025). Both 6hrs and 24 hrs after the surgery, the 
occurrence rate of PONV was lower in Group E than that in 
Group C, but no statistically significant difference was found 
(Table 2).
    Post-operative antiemetics were used in 6 patients of Group 
E (20%) and in 11 patients of Group C (37%) and the difference 
was significant (P=0.04), (Table 2).
    The VAS score 30 minutes post-surgery showed that the posto-
perative pain in Group E (45.1 ± 2.4 mm) was lower compared 
Table 1. Patients’ Characteristics
Group E
(n = 30)
Group C
(n = 30)
Age (yr)
Gneder (male/Female)
Weight (kg)
Height (cm)
Duration of surgery (min)
Duration of anesthesia (min)
Intravenous fluid administrated (ml)
Smoker (n)
History of motion sickness (n)
History of previous PONV (n)
Perioperative esmolol usage (mg)
Perioperative remifentanil usage (μ)
Perioperative propofol usage (mg)
Discharge time (hr)
36.3 ± 7.7
  12/18
61.7 ± 6.3
161.8 ± 6.6
42.5 ± 4.8
57.5 ± 2.8
  895.7 ± 350.3
  4
  8
  1
280.3 ± 43.7
191.2 ± 58.8
410.7 ± 43.5
31.7 ± 8.1
34.5 ± 6.1
  14/16
58.6 ± 6.6
160.4 ± 6.3
41.3 ± 7.2
56.3 ± 5.2
  890.5 ± 375.2
  3
  9
  2
  N/A
  285.4 ± 68.2*
  401.6 ± 38.1
  40.6 ± 9.5*
The data is presented as means ± SDs or the number of patients (n). 
There are no significant differences between the groups. Group E: 
esmolol group, Group C: control group. *P < 0.05 compared with 
Group E.
Table 2. The Incidence and Severity of PONV and Metocloprimde 
Usage
Symptom
Group E
(n = 30)
Group C
(n = 30)
30 min
  Free 
  Mild
  Moderate
  Severe
6 hr
  Free
  Mild
  Moderate
  Severe
24 hr
  Free
  Mild
  Moderate
  Severe
Metocloplamide usage
23 (77)
5 (17)
2 (7)
0 (0)
27 (90)
2 (7)
1 (3)
0 (0)
29 (97)
1 (3)
0 (0)
0 (0)
6 (20)
  13 (43)*
  12 (40)*
  4 (13)
1 (3)
30 (70)
  6 (20)
  3 (10)
0 (0)
28 (93)
2 (7)
0 (0)
0 (0)
11 (37)
The data is expressed as the numbers (percent) of the patient. Group 
E: esmolol group, Group C: control group. *P < 0.05 compared with 
Group E.182 www.ekja.org
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to that of Group C (60.2 ± 4.2 mm) (P = 0.014). Even 6 hr and 
24 hr after the surgery, the VAS score was lower in Group E 
than that in Group C, but there was no statistically significant 
difference (Table 3). 
    The change in MAP at the time of intubation in Group E 
(92.4 ± 11.0 mmHg) was lower than that in Group C (105.6 
± 18.7 mmHg)(P = 0.014). At the time of incision, there was 
no significant difference between the groups. At the time of 
extubation, the MAP in Group E (90.4 ± 16.5 mmHg) was lower 
than that in Group C (98.2 ± 10.9 mmHg)(P = 0.047), (Fig. 1, 
Table 4). There were no other significant differences. 
    The perioperative HR change at the time of endotracheal 
intubation was lower in Group E (81.3 ± 12.4 bpm) than that 
in Group C (101.2 ± 14.8 bpm)(P = 0.024) (Fig. 2). At the time 
of incision, there was no significant difference between the 
two groups. But at the time of extubation, the HR was lower 
in Group E (80.8 ± 11.6 bpm) than that in Group C (94.5 ± 
11.7 bpm) (P = 0.038), (Fig. 2, Table 5). There were no other 
significant differences during the surgery.
Discussion
    PONV and nausea more often occur in cases with the presence 
of perioperative hemodynamic instability, female patients, 
nonsmokers and patients with a past history of PONV or motion 
sickness. General anesthesia using inhalational anesthetics or 
nitrous oxide with the perioperative use of opioids can increase 
nausea and vomiting [3]. In the present study, there was no 
significant difference in such factors as gender, a past history 
of PONV, a history of motion sickness, smoking, the length of 
surgery and the amount of administered fluid. Therefore, the 
differences between Group E and Group C for PONV and pain 
are assumed to be due to the different use and dosage of drugs. 
    The perioperative use of esmolol as an anesthetic supplement 
has been recently reported to decrease the occurrence of 
PONV. Coloma et al. [7] stated that for outpatient gynecologic 
surgeries using desflurane and remifentanil, the use of esmolol 
in anesthesia decreases the occurrence rate of PONV. Ozturk 
et al. [8] reported that for laparoscopic cholecystectomy, the 
use of esmolol and alfentanil together reduces PONV. In the 
present study, Group E had fewer patients who were post-
operatively administered antiemetics compared to that of Group 
C (Table 2). Although there is no definitely agreed upon theory, 
Table 3. VAS Scores and Diclofenac Usage
Group E
(n = 30)
Group C
(n = 30)
VAS score
  30 min
  6 hr
  24 hr
Diclofenac usage (mg)
45.1 ± 2.4
23.1 ± 6.1
17.3 ± 4.5
120 ± 30
60.2 ± 4.2*
33.5 ± 6.3
23.4 ± 5.3
180 ± 75*
The data is presented as means ± SDs. Group E: esmolol group, 
Group C: control group. *P < 0.05 compared with Group E.
Fig. 1. Mean arterial pressure changes during anesthesia. *P < 0.05, 
significant inter-group difference. PACU: post anesthesia care unit.
Fig. 2. Heart rate changes during anesthesia. *P < 0.05, significant 
inter-group differences. PACU: post anesthesia care unit.
Table 4. The Changes of Mean Arterial Pressure (mmHg)
Group E
(n = 30)
Group C
(n = 30)
MBP 1
MBP 2
MBP 3
MBP 4
89.8 ± 13.3
92.4 ± 11.0
91.8 ± 11.2
90.4 ± 16.5
90.2 ± 12.2
105.6 ± 18.7*
95.7 ± 13.1
98.2 ± 10.9*
Data are mean ± SD. MBP 1: mean arterial pressure before anesthetic 
induction, MBP 2: mean arterial pressure of immediately after 
intubation, MBP 3: mean arterial pressure of immediately after 
incision, MBP 4: mean arterial of pressure immediately after 
extubation, Group E: esmolol group, Group C: control group. *P < 
0.05 compared with Group E.183 www.ekja.org
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the perioperative use of β-adrenergic receptor antagonists 
reduces the required dosage of the perioperative opioids, which 
decreases the likelihood of opioids’ side-effects such as nausea 
and vomiting [7,8,10]. To reduce the cardiovascular changes, 
the perioperative use of β-adrenergic receptor antagonists 
alone has no anesthetic effect, but when used as a supplement, 
they have an anesthetic sparing effect [7,9,10]. Coloma et al. 
[7] stated that if desflurane is used for general anesthesia in 
laparoscopic gynecologic surgeries, then esmolol can replace 
remifentanil. Zenichiro et al. [10] stated that the perioperative 
intravenous administration of the β-adrenergic receptor 
antagonist ladiolol reduces the minimal alveolar concentration 
(MAC) of sevoflurane. Johansen et al. [9] stated that when using 
propofol, nitrous oxide and morphine in anesthesia, esmolol 
reduces the required amount of anesthetics needed for a skin 
incision. When a great amount of opioid is used during surgery, 
depressed ventilation, excessive sedation, PONV, tingling, 
difficulty with voiding and ileus occur [11]. Therefore, the 
perioperative use of β-adrenergic receptor antagonists will 
have an opioid sparing effect, which can help prevent PONV [8]. 
In the present study, the administered dosage of remifentanil 
was significantly lower in Group E compared to that of Group 
C (Table 1), which was assumedly brought about the decreased 
PONV and the reduced use of antiemetics. It is currently not clearly 
known if the β-adrenergic receptor antagonist esmolol as a 
perioperative anesthesia supplement has an anesthetic sparing 
effect. Kurita et al. [12] stated that although the β-adrenergic 
receptor antagonist propranolol, which is lipid-soluble, has an 
anesthetic sparing effect in general anesthesia, landiolol and 
esmolol, which are more hydro-soluble, have lower penet-
rability into the blood-brain barrier and so it is unclear whether 
they have such an effect. Further studies on this are needed.
    Another mechanism involved in the prevention of esmolol-
related PONV could be the excessive perioperative cardio-
vascular changes [13]. So the use of esmolol can mitigate such 
perioperative hemodynamic changes and prevent PONV [14,15]. 
    The dosage of remifentanil was set so that the hemodynamic 
changes in the groups would be in the 20% range of the baseline 
rate. But during endotracheal intubation and extubation, 
there were significant differences in the MAP and HR between 
Group E and Group C. The MAP and HR were maintainable in 
Group E because esmolol was used right before intubation and 
extubation.
    Tan et al. [14] reported that the systolic blood pressure 
changes were stable in the patient group that was administered 
1.0 mg/kg and nircadipine 30 μg/kg at the point of intubation as 
compared to that of the control group, which was administered 
natural saline. Dyson et al. [16] stated that the administration 
of esmolol 1.5 mg/kg before extubation will safely maintain the 
systolic blood pressure and HR. Kang et al. [17] stated that to 
keep the occurrence rate of bradycardia and systolic PHT within 
5% due to ETI performed with thiopental sodium, vecuronium, 
and enflurane as anesthesia, the amount of required esmolol is 
around 1 mg/kg. 
    The experiment showed that the levels of PONV and pain 
and the use of analgesics were significantly reduced in Group 
E compared to that of Group C. Yavascaoglu et al. [18] used 
esmolol 0.5 mg/kg for anesthetic induction and they found that 
rocuronium as a muscle relaxant significantly reduces pain 
responses [18]. This was explained by Hageluken et al. [19], who 
stated that the β-adrenergic receptor antagonists have a direct 
effect in activating Gi-protein, which decreases the delivery of the 
spinal pain signals. Avram et al. [20] noted that the β-adrenergic 
receptor antagonists reduce the hepatic blood flow, which 
slows the metabolism of opioids and lengthens their anesthetic 
effect, and this reduces the need for the postoperative use 
of analgesics. Although Lee et al. [21] argued that the use of 
esmolol in laparoscopic gynecologic surgeries reduces the rate 
of PONV and pain (but not significantly), it is assumed that 
they did not simultaneously use esmolol with remifentanil, but 
rather they administered one or the other to a group. Further, 
only the presence/absence of PONV was recorded and the 
levels of PONV were not, which may have contributed to their 
difference compared with our present findings. 
    The mechanism to how perioperative infusion of esmolol reduces 
postoperative pain is explained by the fact that β-adrenergic 
receptor antagonists reduce the necessary perioperative dosage 
of opioids [7,9,10] and they decreases opioid tolerance. Opioids, 
and especially remifentanil or alfentanil, which are short acting 
opioids, they have fast elimination rates and they produce early 
tolerance. The high dosage of perioperative opioids or their 
continuous IV infusion can increase opioid tolerance and bring 
about severe postoperative pain [11,22,23].
    Bruno et al. [22] compared the use of remifentanil with 
desflurane for anesthetic maintenance and they found that 
the group exposed to remifentanil experienced higher levels 
of pain. Also, a higher level of morphine was used as a post-
operative palliative drug in the Group exposed to remifentanil 
Table 5. The Changes of Heart Rate (bpm)
Group E
(n = 30)
Group C
(n = 30)
HR 1
HR 2
HR 3
HR 4
71.6 ± 9.5
81.3 ± 12.4
89.7 ± 9.7
80.8 ± 11.6
72.3 ± 11.2
101.2 ± 14.8*
90.4 ± 9.2
94.5 ± 11.7*
Data are mean ± SD. HR 1: heart rate before anesthetic induction, 
HR 2: heart rate of immediately after intubation, HR 3: heart rate 
of immediately after incision, HR 4: heart rate of immediately after 
extubation, Group E: esmolol group, Group C: control group. *P < 
0.05 compared with Group E.184 www.ekja.org
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but still, the level of PONV was worse than the Group exposed to 
desflurane. This may be due to rapid opioid tolerance. Although 
the tolerance rate is similar regardless of the opioid’s potency, 
the time it takes to develop opioid tolerance is different. 
Alfentanil and remifentanil are short acting opioids with quickly 
developing tolerance [24].
    Laparoscopic appendectomies have shorter recovery times 
and lengths of hospitalization compared to laparatomic 
appen  dectomies. They allow for faster recovery to normal 
daily routines and they have lower incidences of pain [25]. 
However, for better visibility, intraperitoneal CO2 insufflation is 
performed, which works as a vasodilator on the cerebral vessels, 
it increases the cerebral blood flow and cerebral blood pressure, 
and this increases PONV [4]. But when esmolol is used as a 
perioperative supplement, PONV and pain can be reduced and 
there is a faster recovery and return to daily activities. 
    In conclusion, using the perioperative β-adrenergic receptor 
antagonist esmolol as an anesthetic supplement can reduce 
the PONV and pain, but further research that will focus on this 
subject is still needed. 
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